Carcinoma, Large Cell - 23 Studies Found
Recruiting |
: PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers :
|
Completed |
: A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer : Non Small Cell Lung Cancer : 2011-05-26 :
|
Completed |
: ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures : Non-Small-Cell Lung Carcinoma : 2006-11-28 :
|
Completed |
: An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer :
: 2003-02-12 : Biological: EP2101 |
Withdrawn |
: Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer : Carcinoma, Non-Small-Cell-Lung : 2012-07-06 : Drug: Temoporfin A single dose of 0.04 mg per kilogram of body weight of Temoporfin will be administered |
Available |
: An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer :
|
Recruiting |
: ALTA-1L Study: A Phase 3 Study of Brigatinib Versus Crizotinib in ALK-positive Advanced Non-Small Cell Lung Cancer Patients :
|
Active, not recruiting |
: A Phase 2, Multicenter, Randomized Study of AP26113 :
|
Not yet recruiting |
: Clinical Trials Comparing Immunotherapy Plus Stereotactic Ablative Radiotherapy (I-SABR) Versus SABR Alone for Stage I or Isolated Lung Parenchymal Recurrent Non-small Cell Lung Cancer: I-SABR :
: 2017-04-07 : |
Terminated |
: Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) : Non-small-cell Lung Cancer : 2012-01-12 :
|